Top compounds associated with response to NTMT1


Feature Type Standardized
Nominal ANOVA
mRNA itraconazole CTRPv2 pan-cancer AAC -0.094 0.02
mRNA lapatinib CCLE pan-cancer AAC -0.11 0.02
mRNA Panobinostat CCLE pan-cancer AAC -0.098 0.02
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA MS-275 CTRPv2 pan-cancer AAC -0.079 0.02
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.076 0.02
mRNA RO-3306 GDSC1000 pan-cancer AAC 0.081 0.02
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.082 0.02
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.1 0.02
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
Download CSV